Global Neurovascular Devices/Interventional Neurology Market Size By Type (Aneurysm Coiling And Embolization Devices, Cerebral Balloon Angioplasty And Stenting Systems), By Application (Hospitals, Cli...

lobal Neurovascular Devices/Interventional Neurology Market Report Description

The Global Neurovascular Devices/Interventional Neurology Market was valued at USD 3.2 billion in 2023 and is projected to surpass USD 6.7 billion by 2031, expanding at a CAGR of 9.7% during the forecast period (2023–2031). The increasing incidence of neurovascular disorders such as stroke, brain aneurysms, and arteriovenous malformations, coupled with advancements in minimally invasive treatment options, is fueling market growth. The rapid expansion of the aging population and increasing investments in healthcare infrastructure are further driving the adoption of neurovascular devices globally.

Drivers:

1. Rising Prevalence of Neurovascular Disorders:

The growing number of stroke cases and other cerebrovascular conditions globally has led to an increased demand for effective and minimally invasive treatment options, boosting the use of interventional neurology devices.

2. Technological Advancements in Devices:

Innovations such as flow diverters, embolic coils, and thrombectomy systems have significantly improved clinical outcomes, driving wider adoption by healthcare providers.

3. Increasing Healthcare Expenditure and Access to Neurosurgical Care:

Governments and private healthcare institutions are investing heavily in neurovascular care infrastructure, especially in emerging economies, thereby expanding the market potential.

Restraints:

1. High Cost of Neurovascular Procedures and Devices:

The expensive nature of neuro-interventional treatments and devices can limit their adoption, particularly in low-income and underinsured populations.

2. Limited Availability of Skilled Interventional Neurologists:

Despite technological progress, the lack of trained specialists capable of performing complex neurovascular procedures remains a bottleneck, especially in developing regions.

Opportunity:

1. Growth in Emerging Markets:

Asia-Pacific and Latin America are witnessing rising investments in healthcare and an increasing burden of neurological conditions, presenting lucrative opportunities for market expansion.

2. Strategic Collaborations and R&D Initiatives:

Partnerships between device manufacturers and clinical research institutions are leading to next-generation neurovascular tools, creating scope for advanced and targeted treatment strategies.

Market by System Type Insights:

Among the system types, Embolization Devices dominated the market in 2023, accounting for the largest revenue share. These devices are widely used for treating cerebral aneurysms and arteriovenous malformations due to their high efficacy and safety profiles. Neurothrombectomy Devices are expected to register the fastest growth, driven by increasing use in ischemic stroke management.

Market by End-Use Insights:

Hospitals accounted for the highest market share in 2023, owing to the availability of advanced neurosurgical facilities and skilled medical personnel. The Ambulatory Surgical Centers (ASCs) segment is expected to witness significant growth due to shorter hospital stays, cost-effectiveness, and an increasing preference for outpatient procedures.

Market by Regional Insights:

North America held the largest market share in 2023, attributed to robust healthcare infrastructure, high awareness, and widespread adoption of advanced neurovascular interventions. Asia-Pacific is projected to register the highest CAGR during the forecast period, fueled by rising geriatric population, increasing stroke incidence, and improving healthcare access in countries like China and India.

Competitive Scenario:

Leading players in the Global Neurovascular Devices/Interventional Neurology Market include Stryker Corporation, Medtronic plc, Johnson & Johnson (Cerenovus), Penumbra Inc., and MicroVention Inc. (a Terumo Group Company). These companies are focusing on product innovation, geographic expansion, and strategic partnerships. For instance:

In 2023, Stryker introduced a next-gen thrombectomy system designed to enhance clot retrieval efficiency in acute stroke interventions.

Medtronic expanded its neurovascular portfolio in 2024 by launching a new line of flow diverters in Europe and Asia.

Penumbra partnered with a research consortium in 2023 to develop AI-assisted neurovascular navigation tools.

Scope of Work – Global Neurovascular Devices/Interventional Neurology Market

Report Metric Details

Market Size (2023) USD 3.2 billion

Projected Market Size (2031) USD 6.7 billion

CAGR (2023–2031) 9.7%

Key Segments by System Type Embolization Device